Pharmaxis Ltd (AU:SNT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Syntara Limited, an ASX-listed company, has attributed recent trading activity in its securities to investor anticipation of upcoming interim trial data on its SNT-5055 drug, as well as increased coverage by a major broker. The company plans to release the data after peer review at a scientific meeting and maintains that the information remains confidential. Despite market fluctuations, Syntara confirms its compliance with ASX listing rules.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.